200 related articles for article (PubMed ID: 22802291)
1. Hepatocyte growth factor and lung fibrosis.
Crestani B; Marchand-Adam S; Quesnel C; Plantier L; Borensztajn K; Marchal J; Mailleux A; Soler P; Dehoux M
Proc Am Thorac Soc; 2012 Jul; 9(3):158-63. PubMed ID: 22802291
[TBL] [Abstract][Full Text] [Related]
2. The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
Fernandez IE; Eickelberg O
Proc Am Thorac Soc; 2012 Jul; 9(3):111-6. PubMed ID: 22802283
[TBL] [Abstract][Full Text] [Related]
3. Targeted gene transfer of hepatocyte growth factor to alveolar type II epithelial cells reduces lung fibrosis in rats.
Gazdhar A; Temuri A; Knudsen L; Gugger M; Schmid RA; Ochs M; Geiser T
Hum Gene Ther; 2013 Jan; 24(1):105-16. PubMed ID: 23134111
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro.
Shiratori M; Michalopoulos G; Shinozuka H; Singh G; Ogasawara H; Katyal SL
Am J Respir Cell Mol Biol; 1995 Feb; 12(2):171-80. PubMed ID: 7532419
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.
Shukla MN; Rose JL; Ray R; Lathrop KL; Ray A; Ray P
Am J Respir Cell Mol Biol; 2009 Jun; 40(6):643-53. PubMed ID: 18988920
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.
Cahill EF; Kennelly H; Carty F; Mahon BP; English K
Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis.
Gazdhar A; Fachinger P; van Leer C; Pierog J; Gugger M; Friis R; Schmid RA; Geiser T
Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L529-36. PubMed ID: 17056705
[TBL] [Abstract][Full Text] [Related]
9. STAT3: a central mediator of pulmonary fibrosis?
Prêle CM; Yao E; O'Donoghue RJ; Mutsaers SE; Knight DA
Proc Am Thorac Soc; 2012 Jul; 9(3):177-82. PubMed ID: 22802294
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization.
Sakai T; Satoh K; Matsushima K; Shindo S; Abe S; Abe T; Motomiya M; Kawamoto T; Kawabata Y; Nakamura T; Nukiwa T
Am J Respir Cell Mol Biol; 1997 Apr; 16(4):388-97. PubMed ID: 9115749
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.
Liu Y
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F7-16. PubMed ID: 15180923
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma upregulates the c-Met/hepatocyte growth factor receptor expression in alveolar epithelial cells.
Nagahori T; Dohi M; Matsumoto K; Saitoh K; Honda ZI; Nakamura T; Yamamoto K
Am J Respir Cell Mol Biol; 1999 Oct; 21(4):490-7. PubMed ID: 10502559
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis.
Chakraborty S; Chopra P; Hak A; Dastidar SG; Ray A
Expert Opin Investig Drugs; 2013 Apr; 22(4):499-515. PubMed ID: 23484858
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells.
Amenomori M; Mukae H; Ishimatsu Y; Sakamoto N; Kakugawa T; Hara A; Hara S; Fujita H; Ishimoto H; Hayashi T; Kohno S
Exp Lung Res; 2010 Sep; 36(7):411-9. PubMed ID: 20715983
[TBL] [Abstract][Full Text] [Related]
15. Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling.
Ito Y; Correll K; Schiel JA; Finigan JH; Prekeris R; Mason RJ
Am J Physiol Lung Cell Mol Physiol; 2014 Jul; 307(1):L94-105. PubMed ID: 24748602
[TBL] [Abstract][Full Text] [Related]
16. [Hepatocyte growth factor and kidney].
Esposito C; Fasoli G; Rampino T; Dal Canton A
G Ital Nefrol; 2006; 23(4):381-8. PubMed ID: 17063438
[TBL] [Abstract][Full Text] [Related]
17. The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor.
Gazdhar A; Grad I; Tamò L; Gugger M; Feki A; Geiser T
Stem Cell Res Ther; 2014 Nov; 5(6):123. PubMed ID: 25384638
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor is a growth factor for rat alveolar type II cells.
Mason RJ; Leslie CC; McCormick-Shannon K; Deterding RR; Nakamura T; Rubin JS; Shannon JM
Am J Respir Cell Mol Biol; 1994 Nov; 11(5):561-7. PubMed ID: 7524567
[TBL] [Abstract][Full Text] [Related]
19. HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic.
Gazdhar A; Susuri N; Hostettler K; Gugger M; Knudsen L; Roth M; Ochs M; Geiser T
PLoS One; 2013; 8(6):e65453. PubMed ID: 23840329
[TBL] [Abstract][Full Text] [Related]
20. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
